SNX6 Antikörper (N-Term)
-
- Target Alle SNX6 Antikörper anzeigen
- SNX6 (Sorting Nexin 6 (SNX6))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SNX6 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody detects SNX6 at N-term.
- Aufreinigung
- Protein A column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Immunogen
- KLH conjugated synthetic peptide selected from the N-terminal region of human SNX6
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product SNX6 Primärantikörper
-
-
- Applikationshinweise
-
ELISA 1: 1,000. Western blot 1: 50 - 1: 100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS with 0.09 % (W/V) sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
- Target
- SNX6 (Sorting Nexin 6 (SNX6))
- Andere Bezeichnung
- Sorting Nexin-6 (SNX6) (SNX6 Produkte)
- Hintergrund
- SNX6 interacts with members of the transforming growth factor-beta family of receptor serine-threonine kinases. These receptors belong to two classes: type II receptors that bind ligand, and type I receptors that are subsequently recruited to transduce the signal. Of the type II receptors, SNX6 was found to interact strongly with ActRIIB and more moderately with wild type and kinase-defective mutants of TbetaRII. Of the type I receptors, SNX6 was found to interact only with inactivated TbetaRI. SNXs 1-4 also interacted with the transforming growth factor-beta receptor family, showing different receptor preferences. Conversely, SNX6 behaved similarly to the other SNX proteins in its interactions with receptor tyrosine kinases. Strong heteromeric interactions were also seen among SNX1, -2, -4, and -6, suggesting the formation in vivo of oligomeric complexes. These findings are the first evidence for the association of the SNX family of molecules with receptor serine-threonine kinases.
- Molekulargewicht
- 46649 Da
- Gen-ID
- 58533, 9606
- UniProt
- Q9UNH7
- Pathways
- EGFR Signaling Pathway
-